SBP GROUP(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01177 SBP GROUP

Not Yet Opened 07-16 16:08:34

5.260

+0.030

+0.57%

High5.380	Low5.180	Vol100.85M
Open5.240	D1 Closing5.230	Amplitude3.82%
Mkt Cap98.27B	Tradable Cap98.27B	Total Shares18.68B
T/O531.45M	T/O Rate0.54%	Tradable Shares18.68B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"SBP GROUP","latestPrice":5.26,"timestamp":1784189314002,"preClose":5.23,"halted":0,"volume":100847902,"delay":0,"changeRate":0.005736137667303892,"floatShares":18683000000,"shares":18683000000,"eps":0.15024703857852897,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"07-16 16:08:34","open":5.24,"high":5.38,"low":5.18,"amount":531448785,"amplitude":0.038241,"askPrice":5.26,"askSize":1094000,"bidPrice":5.25,"bidSize":58000,"shortable":3,"etf":0,"ttmEps":0.15024703857852897,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784251800000},"marketStatusCode":0,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":5.23,"dividendRate":0.019791,"openAndCloseTimeList":[[1784165400000,1784174400000],[1784178000000,1784188800000]],"volumeRatio":0.626018,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.5394,"impliedVolPercentile":0.7918},"requestUrl":"/m/hq/s/01177/tweets","defaultTab":"tweets","newsList":[{"id":"1150561980","title":"Stock Track | Sino Biopharmaceutical Soars 5.09% Intraday on TRD205 Breakthrough Therapy Designation and Morgan Stanley Earnings Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=1150561980","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150561980?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:57","pubTimestamp":1784080637,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical's stock surged 5.09% during intraday trading on Wednesday, following positive developments regarding its pipeline drug and analyst optimism.The company announced that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168965549","title":"Movement Alert｜Sino Biopharmaceutical Rises 3.72% in Regular Trading, TRD205 Granted Breakthrough Therapy Designation Plus Morgan Stanley Raises Earnings Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1168965549","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168965549?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:55","pubTimestamp":1784080521,"startTime":"0","endTime":"0","summary":"On July 15, Sino Biopharmaceutical rose 3.72% in regular trading, trading at HKD 5.32/share, with turnover of HKD 108 million.On the news front, the company announced on July 14 that its subsidiary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651210768","title":"Sino Biopharmaceutical Says Trd205 Granted Breakthrough Therapy Designation by China's","url":"https://stock-news.laohu8.com/highlight/detail?id=2651210768","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651210768?lang=en_us&edition=fundamental","pubTime":"2026-07-14 23:25","pubTimestamp":1784042741,"startTime":"0","endTime":"0","summary":"BRIEF-Sino Biopharmaceutical Says Trd205 Granted Breakthrough Therapy Designation By China'sJuly 14 (Reuters)-Sino Biopharmaceutical Ltd1177.HK:TRD205 GRANTED BREAKTHROUGH THERAPY DESIGNATION BY CHINA'S CDE AFTER PHASE II TRIAL FOR CPSNPFurther company coverage:1177.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G0HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1521","BK1191","01177","IE00BZ08YR35.GBP","HK0000165453.HKD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651081201","title":"Sino Biopharma Unit Gets Breakthrough Therapy Designation for Neuropathic Pain Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2651081201","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651081201?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:48","pubTimestamp":1784029721,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical  unit Beijing Tide Pharmaceutical's TRD205 obtained breakthrough therapy designation from China's National Medical Products Administration.The move came following positive results from a phase II clinical trial of the drug for chronic post-surgical neuropathic pain, according to a Tuesday Hong Kong bourse filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","01177","BK1589","BK1521","BK1191","IE00BZ08YS42.EUR","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182969144","title":"SBP GROUP's TRD205 AT2R Antagonist Receives Breakthrough Therapy Designation from CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=1182969144","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182969144?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:34","pubTimestamp":1784025276,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) has announced that TRD205, a novel AT2R antagonist developed by its subsidiary Beijing Tide Pharmaceutical Co., Ltd., has been included in the Breakthrough Therapy Drug List by the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4017","BK1191","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","SIL","IE00BZ08YT58.USD","01177","XME","LU1223083913.SGD","BK1589","LU1223082196.USD","HK0000165453.HKD","BK1515","LU1223082519.USD","BK1521","CDE","SGDM","GDXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651850172","title":"Sino Biopharmaceutical - Trd205 Granted Breakthrough Therapy Designation by China's Cde After Phase Ii Trial for Cpsnp","url":"https://stock-news.laohu8.com/highlight/detail?id=2651850172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651850172?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:28","pubTimestamp":1784024891,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G0HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1515","BK1521","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","01177","HK0000165453.HKD","BK1589","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651175813","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2651175813","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651175813?lang=en_us&edition=fundamental","pubTime":"2026-07-14 16:33","pubTimestamp":1784017980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 1.0% to 5.11 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24340.73.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 44% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.6% and Amgen Inc. remained unchanged.Trading volume totaled 131.1 million shares, compared to the 50-day average of 96.0 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 14, 2026 04:33 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU2242652126.USD","IE00BZ08YR35.GBP","IE0002141913.USD","IE00BZ08YT58.USD","IE0009355771.USD","LU0122379950.USD","IE00B4R5TH58.HKD","HK0000165453.HKD","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4599","BK4139","AMGN","LU1061106388.HKD","LU0058720904.USD","BK4566","BK1515","BK4533","BK1521","LU2242646821.SGD","PJP","BK4534","BK4581","LU2089984988.USD","01177","LU1023059063.AUD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU2112291526.USD","LU1571399168.USD","LU2468319806.SGD","IBB","BBH","BK1191","IE00BZ08YS42.EUR","BIB","LU0289739699.SGD","SG9999001440.SGD","LU0868494617.USD","BK1589","LU1983299246.USD","BK4585","PBE","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150857600","title":"Morgan Stanley Adjusts Earnings Per Share Forecasts for SBP GROUP Through 2028, Reiterates 'Overweight' Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1150857600","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150857600?lang=en_us&edition=fundamental","pubTime":"2026-07-14 15:10","pubTimestamp":1784013021,"startTime":"0","endTime":"0","summary":"Morgan Stanley has issued a research report updating its financial projections for SBP GROUP (01177). The bank has largely maintained its forecasts for the company's innovative drugs. However, it has...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","HK0000165453.HKD","01177","IE00BZ08YT58.USD","BK1574","IE00BZ08YS42.EUR","BK1521","IE00BZ08YR35.GBP","BK1191","BK1589","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651522194","title":"Sino Biopharm Files HKEX Next-day Return Disclosing Share Buyback Cancellation at HKD 4.46 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2651522194","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651522194?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:19","pubTimestamp":1783930768,"startTime":"0","endTime":"0","summary":"Sino Biopharm files HKEX next-day return disclosing share buyback cancellation at HKD 4.46 eachSino Biopharmaceutical filed a next-day disclosure return showing 22,065,000 shares repurchased and cancelled.Buyback price averaged HKD 4.46 per share; issued shares fell 0.12% to 18,682,952,230 as of July 13.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on July 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL4Y6zXP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","BK1191","BK1521","IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1515","BK1589","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176804633","title":"SBP Group receives CDE acceptance for TQB3454 NDA targeting IDH1-mutant biliary tract cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1176804633","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176804633?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:06","pubTimestamp":1783674409,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical Limited (SBP Group) announced that China’s Center for Drug Evaluation has accepted the New Drug Application (NDA) for TQB3454, an orally administered IDH1 inhibitor developed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166990917","title":"Innovative Drug TQB3454 from SBP Group's Subsidiary Seeks Market Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1166990917","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166990917?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:04","pubTimestamp":1783674294,"startTime":"0","endTime":"0","summary":"An announcement from SBP GROUP (01177) reveals that its subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., has submitted a New Drug Application (NDA) for its self-developed Class 1...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","IE00BZ08YT58.USD","BK1589","IPOS","01177","BK1191","BK1515","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650851761","title":"Sino Biopharm Says China Regulator Accepts NDA for Tqb3454 IDH1 Inhibitor in Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2650851761","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650851761?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:00","pubTimestamp":1783674017,"startTime":"0","endTime":"0","summary":"Sino Biopharm says China regulator accepts NDA for TQB3454 IDH1 inhibitor in biliary tract cancerSino Biopharmaceutical’s CTTQ unit won CDE acceptance of a China NDA for TQB3454, an IDH1 inhibitor for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL7NDYVX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1589","HK0000165453.HKD","01177","IE00BZ08YR35.GBP","BK1521","IE00BZ08YS42.EUR","BK1191","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185918","title":"Sino Biopharmaceutical - China's Cde Accepts Nda for Tqb3454 Tablet 'idh1 Inhibitor' for Advanced BTC with Idh1 Mutations","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185918","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650185918?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:58","pubTimestamp":1783673923,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C014:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1589","BK1515","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","01177","BK1521","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650718397","title":"Sino Biopharmaceutical Stock Advances 3.8% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2650718397","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650718397?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:31","pubTimestamp":1783672260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 3.8% to 5.19 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.6% to 24175.12.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 43% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 3.4% and Amgen Inc. remained unchanged.Trading volume totaled 177.3 million shares, compared to the 50-day average of 92.1 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 10, 2026 04:31 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1515","LU0122379950.USD","LU2242652126.USD","BBH","AMGN","BK4588","LU2468319806.SGD","01177","LU0889565916.HKD","LU1023059063.AUD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","SG9999001440.SGD","PJP","IE00BJJMRZ35.SGD","IBBQ","BK4534","BK1521","PBE","IBB","BK4566","LU1571399168.USD","LU1057294990.SGD","BK4581","IE0002141913.USD","BK1589","IE00BZ08YT58.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0320765992.SGD","LU0109394709.USD","LU0058720904.USD","BK4533","LU1061106388.HKD","LU2112291526.USD","BK4599","BK1191","IE0009355771.USD","BIB","IE00B4R5TH58.HKD","BK4585","IE00B2B36J28.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","HK0000165453.HKD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119759938","title":"Stock Track | Sino Biopharmaceutical Soars 5.00% Intraday on AstraZeneca and GSK Partnerships and NDA Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1119759938","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119759938?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:35","pubTimestamp":1783650915,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical's stock price soared 5.00% during intraday trading on Friday, following significant positive developments from the company.The surge comes after the company announced that its...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120510047","title":"Movement Alert｜Sino Biopharmaceutical Rises 3.2% in Regular Trading, AstraZeneca and GSK Dual Partnerships Continue to Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1120510047","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120510047?lang=en_us&edition=fundamental","pubTime":"2026-07-10 10:05","pubTimestamp":1783649157,"startTime":"0","endTime":"0","summary":"On July 10, Sino Biopharmaceutical rose 3.2% in regular trading, trading at HK$5.17/share, with turnover of HK$166 million. The stock continued its upward momentum following the announcement of two...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650990864","title":"Why Sino Biopharmaceutical (SEHK:1177) Is Up 8.2% After New Global Respiratory Deals And NDA Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2650990864","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650990864?lang=en_us&edition=fundamental","pubTime":"2026-07-10 07:35","pubTimestamp":1783640139,"startTime":"0","endTime":"0","summary":"In recent days, Sino Biopharmaceutical announced that its subsidiary Beijing Tide had an NDA for a world-first long-acting ropivacaine hydrochloride sustained-release solution for postoperative analgesia accepted by China’s Center for Drug Evaluation, while another subsidiary granted AstraZeneca exclusive ex-China rights to the inhaled respiratory drug TQC3721 and expanded a respiratory medicines partnership with GSK in mainland China.\nThe AstraZeneca licence, which includes a US$200 million...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/why-sino-biopharmaceutical-sehk1177-is-up-82-after-new-globa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1177/sino-biopharmaceutical-shares/news/why-sino-biopharmaceutical-sehk1177-is-up-82-after-new-globa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1589","BK1515","01177","BK1191","HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650744942","title":"Sino Biopharmaceutical Stock Rises 3.7% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2650744942","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650744942?lang=en_us&edition=fundamental","pubTime":"2026-07-09 16:30","pubTimestamp":1783585800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rose 3.7% to 5.00 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.7% to 24030.18.Sino Biopharmaceutical Ltd. closed 45% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. remained unchanged and Amgen Inc. remained unchanged.Trading volume totaled 146.9 million shares, compared to the 50-day average of 90.9 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 09, 2026 04:30 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU2468319806.SGD","BK1191","BK4139","LU0889565916.HKD","LU1061106388.HKD","PJP","IE0002141913.USD","LU1571399168.USD","BK4566","LU2089984988.USD","BK4533","LU0122379950.USD","LU0289739699.SGD","BK1521","IE00BZ08YT58.USD","BK4588","LU2242652126.USD","PBE","IE0009355771.USD","BK4581","LU1057294990.SGD","LU0868494617.USD","IBB","IE00B2B36J28.USD","AMGN","BK1589","IBBQ","BK4534","LU1023059063.AUD","BK1515","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4599","IE00BFTCPJ56.SGD","BBH","IE00BZ08YS42.EUR","SG9999001440.SGD","BIB","LU0058720904.USD","IE00BJT1NW94.SGD","IE00BZ08YR35.GBP","LU0109394709.USD","LU1983299246.USD","01177","IE00B4R5TH58.HKD","LU2112291526.USD","BK4585","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115056703","title":"SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE","url":"https://stock-news.laohu8.com/highlight/detail?id=1115056703","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115056703?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563660,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) climbed more than 5% during the morning session. At the time of writing, the stock was up 5.39% to HK$5.08, with a turnover of HK$239 million. Expanding a Strategic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1521","IE00BZ08YS42.EUR","BK4532","GSKH","BK4007","GSK","BK1515","BK1589","01177","BK4588","HK0000165453.HKD","GSK.UK","IE00BZ08YT58.USD","BK4585","LU1829250122.USD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170050464","title":"Stock Track | SBP GROUP Soars 5.19% Intraday on AstraZeneca and GSK Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=1170050464","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170050464?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:03","pubTimestamp":1783562601,"startTime":"0","endTime":"0","summary":"SBP GROUP's stock price surged 5.19% during intraday trading on Thursday, following the announcement of significant new licensing agreements.The company has entered into a major licensing deal with...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":0.0851},{"period":"1month","weight":0.1066},{"period":"3month","weight":-0.1342},{"period":"6month","weight":-0.2388},{"period":"1year","weight":-0.1641},{"period":"ytd","weight":-0.144}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":-0.0065},{"period":"3month","weight":-0.0649},{"period":"6month","weight":-0.0806},{"period":"1year","weight":0.0037},{"period":"ytd","weight":-0.037}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.","yearOnYearQuotes":[{"month":1,"riseRate":0.434783,"avgChangeRate":0.007657},{"month":2,"riseRate":0.652174,"avgChangeRate":0.056403},{"month":3,"riseRate":0.565217,"avgChangeRate":0.046203},{"month":4,"riseRate":0.478261,"avgChangeRate":0.020807},{"month":5,"riseRate":0.695652,"avgChangeRate":0.037978},{"month":6,"riseRate":0.347826,"avgChangeRate":0.004739},{"month":7,"riseRate":0.652174,"avgChangeRate":0.054314},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.010627},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.014397},{"month":10,"riseRate":0.545455,"avgChangeRate":0.024699},{"month":11,"riseRate":0.5,"avgChangeRate":0.067223},{"month":12,"riseRate":0.409091,"avgChangeRate":-0.012172}],"exchange":"SEHK","name":"SBP GROUP","nameEN":"SBP GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SBP GROUP(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SBP GROUP(01177) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SBP GROUP,01177,SBP GROUP股票,SBP GROUP股票老虎,SBP GROUP股票老虎国际,SBP GROUP行情,SBP GROUP股票行情,SBP GROUP股价,SBP GROUP股市,SBP GROUP股票价格,SBP GROUP股票交易,SBP GROUP股票购买,SBP GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SBP GROUP(01177),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SBP GROUP(01177) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}